MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

|||

Balance Sheets Overview

Current Ratio
356.30%
Quick Ratio
356.30%
Cash Ratio
335.22%
Debt to Asset Ratio
28.07%
Unit: Dollar
Assets Breakdown
    • Prepaid clinical trial costs
    • Prepaid expenses and other curre...
    • Non-current prepaid clinical tri...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued clinical expenses
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
19,889,960
22,190,231
14,438,792
13,183,259
Prepaid clinical trial costs
849,721
819,721
0
81,742
Prepaid expenses and other current assets
400,909
549,684
664,685
247,927
Total current assets
21,140,590
23,559,636
15,103,477
13,512,928
Non-current prepaid clinical trial costs
0
0
819,721
819,721
Total assets
21,140,590
23,559,636
15,923,198
14,332,649
Short-term debt
144,093
231,274
406,875
0
Accounts payable
2,456,152
2,085,268
3,009,074
5,431,806
Accrued clinical expenses
2,588,464
2,675,687
2,582,094
2,891,175
Accrued compensation
497,462
408,519
485,899
784,956
Other accrued liabilities
247,174
718,407
791,611
630,471
Total current liabilities
5,933,345
6,119,155
7,275,553
9,738,408
Warrant liabilities
-
-
0
44,506
Total liabilities
5,933,345
6,119,155
7,275,553
9,782,914
Common stock, par value of 0.0001 515,000,000 shares authorized 13,110,377 and 5,872,865 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
12,378
12,348
11,655
9,618
Additional paid-in capital
204,976,637
204,762,072
192,773,942
185,310,390
Accumulated deficit
-189,781,770
-187,333,939
-184,137,952
-180,770,273
Total stockholders' equity
15,207,245
17,440,481
8,647,645
4,549,735
Total liabilities and stockholders equity
21,140,590
23,559,636
15,923,198
14,332,649
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$19,889,960 (91.92%↑ Y/Y)Prepaid clinical trialcosts$849,721 (713.54%↑ Y/Y)Prepaid expenses andother current assets$400,909 (15.55%↑ Y/Y)Total current assets$21,140,590 (95.47%↑ Y/Y)Total assets$21,140,590 (81.70%↑ Y/Y)Total liabilities andstockholders equity$21,140,590 (81.70%↑ Y/Y)Total stockholders'equity$15,207,245 (3412.06%↑ Y/Y)Total liabilities$5,933,345 (-50.94%↓ Y/Y)Accumulated deficit-$189,781,770 (-7.37%↓ Y/Y)Additional paid-in capital$204,976,637 (16.27%↑ Y/Y)Total currentliabilities$5,933,345 (-50.87%↓ Y/Y)Common stock, par valueof 0.0001...$12,378 (82.03%↑ Y/Y)Accrued clinicalexpenses$2,588,464 (-52.68%↓ Y/Y)Accounts payable$2,456,152 (-50.57%↓ Y/Y)Accrued compensation$497,462 (-17.45%↓ Y/Y)Other accruedliabilities$247,174 (-73.21%↓ Y/Y)Short-term debt$144,093 (27.24%↑ Y/Y)